482 related articles for article (PubMed ID: 7045227)
1. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.
Kelso A; Munck A
J Immunol; 1984 Aug; 133(2):784-91. PubMed ID: 6203981
[TBL] [Abstract][Full Text] [Related]
3. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
Kelso A; Glasebrook AL
J Immunol; 1984 Jun; 132(6):2924-31. PubMed ID: 6202766
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
6. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
8. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms involved in T cell activation. III. The role of extracellular calcium in antigen-induced lymphokine production and interleukin 2-induced proliferation of cloned cytotoxic T lymphocytes.
Harris DT; Kozumbo WJ; Testa JE; Cerutti PA; Cerottini JC
J Immunol; 1988 Feb; 140(3):921-7. PubMed ID: 3276784
[TBL] [Abstract][Full Text] [Related]
10. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes.
Prystowsky MB; Ely JM; Beller DI; Eisenberg L; Goldman J; Goldman M; Goldwasser E; Ihle J; Quintans J; Remold H; Vogel SN; Fitch FW
J Immunol; 1982 Dec; 129(6):2337-44. PubMed ID: 6216281
[TBL] [Abstract][Full Text] [Related]
11. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-activating factors from different T cell clones induce distinct macrophage functions.
Gemsa D; Debatin KM; Kramer W; Kubelka C; Deimann W; Kees U; Krammer PH
J Immunol; 1983 Aug; 131(2):833-44. PubMed ID: 6190940
[TBL] [Abstract][Full Text] [Related]
13. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes.
Harris DT; Kozumbo WJ; Cerutti P; Cerottini JC
J Immunol; 1987 Jan; 138(2):600-5. PubMed ID: 3540123
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
Orosz CG; Zinn NE; Olsen RG; Mathes LE
J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
18. Clonal heterogeneity in colony stimulating factor production by murine T lymphocytes.
Kelso A; Metcalf D
J Cell Physiol; 1985 Apr; 123(1):101-10. PubMed ID: 3156138
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]